Knowledge Base

Resources & Guides

Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.

Showing articles tagged: #side-effects Clear filter

Educational Content

View all →
Showing 6 of 6 articles
No articles found matching your search. Try a different term or view all articles.

Wegovy Pill Side Effects: What the FDA Label Reports

The oral Wegovy tablet carries the same GLP-1 side effect profile as the rest of the class, but the FDA label handles it differently from the injection. The pen gets a full per-symptom adverse reaction table. The tablet does not. This guide covers what the label actually reports for each format, the dose-ladder timing of GI symptoms, discontinuation rates, the boxed warning, and management strategies.

Microdosing GLP-1 Side Effects: What the Dose-Response Data Shows

A pharmacokinetics-anchored look at microdosing GLP-1 side effects across semaglutide, tirzepatide, and retatrutide: what trial dose-response data tells us about lower-dose GI tolerability, and which class-level serious risks persist at every dose.

Microdosing GLP-1 Medications: Complete Guide to Split Dosing

Everything you need to know about microdosing GLP-1 agonists. Split dosing protocols for retatrutide, tirzepatide, and semaglutide to reduce side effects without sacrificing weight loss results.

Retatrutide (GLP-3) Dosing Guide: 2mg to 12mg Protocol

Complete GLP-3 retatrutide dosage guide covering the 2mg to 12mg weekly titration protocol, printable dosing chart, half-life pharmacokinetics, weight loss results from clinical trials, side effects management, and a free interactive dosing calculator.

Complete Tirzepatide Dosing Guide (2026)

Everything you need to know about tirzepatide dosing: dual-agonist mechanism, clinical trial efficacy data, starting dose through maintenance, titration schedules, half-life pharmacokinetics, side effects, and dosing calculator.

Complete Semaglutide Dosing Guide (2026)

Everything you need to know about semaglutide dosing: GLP-1 mechanism, clinical trial efficacy data, starting dose through maintenance, titration schedules, half-life pharmacokinetics, side effects, and how to use a dosing calculator.